Advertisement

Journal of Endocrinological Investigation

, Volume 12, Issue 10, pp 717–721 | Cite as

Localized myxedema on the nasal dorsum in a patient with Graves’ disease: Report of a case

  • F. Akasu
  • K. Takazawa
  • R. Akasu
  • T. Onaya
Case Report

Abstract

We report the case of a 56-year-old Japanese female with Graves’ disease associated with localized myxedema on the nasal dorsum. The patient developed localized myxedema concomitantly with hyperthyroidism before antithyroid therapy was given. The lesion was totally removed surgically, as it was small and well circumscribed. Although unusual locations of localized myxedema have been reported elsewhere, there is to date no case of localized myxedema on the nasal dorsum without involvement of the pretibial area reported in the literature. We discuss this unique feature of our patient.

Key-words

Localized myxedema Graves’ disease hyperthyroidism LATS TBII 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Gimlette T. Pretibial myxoedema. Br. Med. J. 2: 348, 1960.PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.
    Haydar N.A. Exophthalmos, digital clubbing and pretibial myxedema in thyroiditis. J. Clin. Endocrinol. Metab. 23: 215, 1963.PubMedCrossRefGoogle Scholar
  3. 3.
    Horiuch Y. Pretibial myxedema associated with chronic thyroiditis. Arch. Dermatol. 121: 451, 1985.CrossRefGoogle Scholar
  4. 4.
    Stewart G., Rowland Payne C.M.E., Croft D.N. Hashimoto’s thyroiditis associated with dysthyroid eye disease, pretibial myxedema and thyroid acropathy. J. Roy. Soc. Med. 77: 240, 1980.Google Scholar
  5. 5.
    Lynch P.J., Maize J.C., Sisson J.C. Pretibial myxedema and non-thyrotoxic thyroid disease. Arch. Dermatol. 107: 107, 1973.PubMedCrossRefGoogle Scholar
  6. 6.
    Kasagi K., Konishi J., Arai K., Misaki T., Iida Y., Endo K., Torizuka, K. A sensitive and practical assay for thyroid-stimulating antibodies using crude immunoglobulin fractions precipitated with polyethylene glycol. J. Clin. Endocrinol. Metab. 62: 855, 1986.PubMedCrossRefGoogle Scholar
  7. 7.
    Kasagi K., Konishi J., Iida Y., Tokuda Y., Arai K., Endo K., Torizuka K. A sensitive and practical assay for thyroid-stimulating antibodies using FRTL-5 thyroid cells. Acta Endocrinol. (Copenh.) 115: 30, 1987.Google Scholar
  8. 8.
    Southgate K., Creeagh F., Teece M., Kingswood C., Smith B.R. A receptor assay for the measurement of TSH receptor antibodies in unextracted serum. Clin. Endocrinol. (Oxf.) 20: 539, 1984.CrossRefGoogle Scholar
  9. 9.
    Cairns R.J. Pretibial myxedema. In: Rook A., Wilkinson D.S., Ebling F.J.G. (Eds.), Textbook of Dermatology. Blackwell Scientific Publisher, Oxford-Edinburgh, 1972, p. 107.Google Scholar
  10. 10.
    Sisson J.C. Hyalunic acid in localized myxedema. J. Clin. Endocrinol. Metab. 28: 433, 1968.PubMedCrossRefGoogle Scholar
  11. 11.
    Cohen B.D., Benua R.S., Rawson R.W. Localized myxedema involving the upper extremities. Arch. Intern. Med. 111: 153, 1963.CrossRefGoogle Scholar
  12. 12.
    Sunseri J. Elephantiasic papulonodular myxedema. Arch. Dermatol. Syph. 48: 70, 1943.CrossRefGoogle Scholar
  13. 13.
    Braverman I.M. Endocrine and Metabolic Diseases. In: Braverman I.M. (Eds.), Skin Signs of Systemic Diseases. WB Saunders Co., Philadelphia, 1981, p. 613.Google Scholar
  14. 14.
    Slater D.N. Cervical nodular localized myxoedema in a thyroidectomy scar: light and electron microscopy and histochemical findings. Clin. Exp. Dermatol. 12: 216, 1987.PubMedCrossRefGoogle Scholar
  15. 15.
    Noppakun N., Bancleun K., Chaudraprasert S. Unusual localization of localized myxedema in Graves’ disease. Arch. Dermatol. 122: 85, 1986.PubMedCrossRefGoogle Scholar
  16. 16.
    Nixon D.W., Samols E. Acral changes associated with thyroid disease. JAMA 212: 1175, 1970.PubMedCrossRefGoogle Scholar
  17. 17.
    Schermer D.R., Roenigk H.H. Jr., Schumacher O.P., McKenzie J.M. Relationship of long-acting thyroid stimulator to pretibial myxedema. Arch. Dermatol. 102: 62, 1970.PubMedCrossRefGoogle Scholar
  18. 18.
    Cheung H.S., Nicoloff J.T., Kamiel M.B., Spolter L., Nimni M.E. Stimulation of fibroblast biosynthetic activity by serum of patients with pretibial myxedema. J. Invest. Dermatol. 71: 12, 1978.PubMedCrossRefGoogle Scholar
  19. 19.
    Jolliffe D.S., Gaylarde P.M., Brock A.P., Sarkang I. Pretibial myxoedema: stimulation of mucopolysaccharide production of fibroblasts by serum. Br. J. Dermatol. 101: 557, 1979.PubMedCrossRefGoogle Scholar
  20. 20.
    Konrad K., Brenner W., Pehamberger H. Ultrastructure and immunological findings in Graves’ disease with pretibial myxedema. J. Cutan. Pathol. 7: 99, 1980.PubMedCrossRefGoogle Scholar
  21. 21.
    Dandona P., Marshall N.J., Bidey S.P. Successful treatment of exophthalmos and pretibial myxedema with plasmapheresis. Br. Med. J. 1: 373, 1979.Google Scholar
  22. 22.
    Lewis R.A., Slaton N., Croft D.N. Exophthalmos and pretibial myxoedema not responding to plasmapheresis. Br. Med. J. 2: 390, 1979.PubMedCentralPubMedCrossRefGoogle Scholar
  23. 23.
    Kriss J.P., Pleshakov V., Rosenblum A. Therapy with occlusive dressing of pretibial myxedema with fluocinolone acetonide. J. Clin. Endocrinol. Metab. 27: 595, 1967.PubMedCrossRefGoogle Scholar
  24. 24.
    Inch R.S. Localized pretibial myxoedema treated with cortisone. Lancet. 2: 1239, 1953.CrossRefGoogle Scholar
  25. 25.
    Kucer K.A., Lucombe H.A., Kauh Y.C. Pretibial myxedema: recurrence after skin grafting. Arch. Dermatol. 116: 1076, 1980.PubMedCrossRefGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 1989

Authors and Affiliations

  • F. Akasu
    • 1
  • K. Takazawa
    • 1
  • R. Akasu
    • 2
  • T. Onaya
    • 1
  1. 1.Third Department of Internal MedicineUniversity of Yamanashi Medical SchoolTamahoJapan
  2. 2.Department of DermatologyUniversity of Yamanashi Medical SchoolYamanashiJapan

Personalised recommendations